ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 26 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $59,000 | +31.1% | 56,222 | 0.0% | 0.00% | – |
Q4 2017 | $45,000 | -48.9% | 56,222 | 0.0% | 0.00% | – |
Q3 2017 | $88,000 | 0.0% | 56,222 | 0.0% | 0.00% | – |
Q2 2017 | $88,000 | -14.6% | 56,222 | +19.1% | 0.00% | – |
Q1 2017 | $103,000 | +15.7% | 47,187 | +0.6% | 0.00% | – |
Q4 2016 | $89,000 | -31.5% | 46,887 | +0.4% | 0.00% | – |
Q3 2016 | $130,000 | +68.8% | 46,687 | +0.1% | 0.00% | – |
Q2 2016 | $77,000 | +450.0% | 46,637 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -90.0% | 46,637 | -0.1% | 0.00% | – |
Q4 2015 | $140,000 | +25.0% | 46,687 | +0.2% | 0.00% | – |
Q3 2015 | $112,000 | -14.5% | 46,587 | +0.2% | 0.00% | – |
Q2 2015 | $131,000 | -62.4% | 46,487 | +18.8% | 0.00% | – |
Q1 2015 | $348,000 | -5.2% | 39,125 | +26.4% | 0.00% | – |
Q4 2014 | $367,000 | +7.0% | 30,960 | +0.5% | 0.00% | – |
Q3 2014 | $343,000 | +9.6% | 30,810 | +29.5% | 0.00% | – |
Q2 2014 | $313,000 | -10.6% | 23,791 | +10.1% | 0.00% | – |
Q1 2014 | $350,000 | – | 21,617 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,907,008 | $21,244,000 | 14.99% |
Third Rock Ventures, LLC | 4,841,591 | $53,935,000 | 6.29% |
Broadfin Capital, LLC | 857,715 | $9,555,000 | 1.00% |
NJ State Employees Deferred Compensation Plan | 25,000 | $278,000 | 0.06% |
SECTORAL ASSET MANAGEMENT INC | 112,485 | $1,253,000 | 0.05% |
C WorldWide Group Holding A/S | 100,000 | $1,161,000 | 0.02% |
Tower Research Capital LLC (TRC) | 9,921 | $111,000 | 0.01% |
SABBY MANAGEMENT, LLC | 19,997 | $223,000 | 0.01% |
Ground Swell Capital, LLC | 402 | $4,000 | 0.01% |
Point72 Asset Management, L.P. | 55,450 | $618,000 | 0.01% |